ACQUIRED FACTOR V DEFICIENCY

ACQUIRED FACTOR V DEFICIENCY was reported 110 times

These drug classes are most commonly taken by patients reporting ACQUIRED FACTOR V DEFICIENCY:

# Drug Count
0 Corticosteroid [EPC] 53
1 Factor Xa Inhibitor [EPC] 53
2 Anti-IgE [EPC] 49
3 Catecholamine [EPC] 27
4 alpha-Adrenergic Agonist [EPC] 27
5 beta-Adrenergic Agonist [EPC] 27
6 Interleukin-5 Antagonist [EPC] 26
7 Aminoglycoside Antibacterial [EPC] 14
8 Nonsteroidal Anti-inflammatory Drug [EPC] 8
9 P2Y12 Platelet Inhibitor [EPC] 8
10 Penem Antibacterial [EPC] 7
11 Platelet Aggregation Inhibitor [EPC] 7
12 Proton Pump Inhibitor [EPC] 7
13 Fluoroquinolone Antibacterial [EPC] 5
14 Folate Analog Metabolic Inhibitor [EPC] 4
15 Loop Diuretic [EPC] 4
16 HMG-CoA Reductase Inhibitor [EPC] 3
17 Programmed Death Receptor-1 Blocking Antibody [EPC] 3
18 Vitamin K [EPC] 3
19 Warfarin Reversal Agent [EPC] 3
20 Aldosterone Antagonist [EPC] 2
21 Calcium Channel Blocker [EPC] 2
22 Dihydropyridine Calcium Channel Blocker [EPC] 2
23 Macrolide Antimicrobial [EPC] 2
24 Macrolide [EPC] 2
25 Nitrate Vasodilator [EPC] 2
26 Rifamycin Antibacterial [EPC] 2
27 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 2
28 Vascular Endothelial Growth Factor Inhibitor [EPC] 2
29 Vasopressin V2 Receptor Antagonist [EPC] 2
30 Vitamin B12 [EPC] 2
31 Xanthine Oxidase Inhibitor [EPC] 2
32 beta-Adrenergic Blocker [EPC] 2
33 Alkylating Drug [EPC] 1
34 Antifibrinolytic Agent [EPC] 1
35 Asparagine-specific Enzyme [EPC] 1
36 CD20-directed Cytolytic Antibody [EPC] 1
37 Glycopeptide Antibacterial [EPC] 1
38 Integrin Receptor Antagonist [EPC] 1
39 Interleukin-23 Antagonist [EPC] 1
40 Kinase Inhibitor [EPC] 1
41 Lipopeptide Antibacterial [EPC] 1
42 Microtubule Inhibitor [EPC] 1
43 Nitroimidazole Antimicrobial [EPC] 1
44 Nucleoside Metabolic Inhibitor [EPC] 1
45 Osmotic Laxative [EPC] 1
46 Oxazolidinone Antibacterial [EPC] 1
47 Platinum-based Drug [EPC] 1
48 Somatostatin Analog [EPC] 1